Fighting Antimicrobial-Resistant HAIs
Diagnostics are key to preventing and controlling this growing global threat.
Read MorePosted by Laurie Bonner | Oct 27, 2020 | Infectious Diseases, Microbiology |
Diagnostics are key to preventing and controlling this growing global threat.
Read MorePosted by Laurie Bonner | Sep 29, 2020 | Diabetes & Metabolic Diseases, Hematology & Serology |
LabCorp will develop and commercialize a blood-based molecular diagnostic test powered by NIS4 technology to help identify patients with at-risk nonalcoholic steatohepatitis.
Read MorePosted by Melanie Hamilton-Basich | Aug 8, 2020 | Diabetes & Metabolic Diseases |
The combined type 1 diabetes risk score approach incorporates genetics, clinical factors such as family history, and the count of islet autoantibodies.
Read MorePosted by Laurie Bonner | Jul 8, 2020 | Covid 19, Uncategorized |
Clinical laboratories are running more tests and a greater variety of tests than they were able to in recent months.
Read MorePosted by Laurie Bonner | Jul 5, 2020 | Prenatal Testing |
The discovery of two novel biomarkers—FKBPL and CD44—has the potential to change the way preeclampsia is managed.
Read More